Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - paracetamol - oral suspension - 120 mg/5ml - anilides; paracetamol

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

cupal limited - paracetamol - oral suspension - 120 mg/5 m %v/v

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

chefaro ireland dac - magnesium hydroxide - oral suspension - 415 mg/5ml - magnesium compounds; magnesium hydroxide

Singapur - inglise - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - immunoglobulin g - injection, powder, for solution - 48-56 mg/ml - immunoglobulin g 48-56 mg/ml

Malta - inglise - Malta Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - paracetamol - oral suspension - paracetamol 120 mg/5ml - analgesics

Malta - inglise - Malta Medicines Authority

omega pharma limited 1st floor, 32 vauxhall bridge road, london sw1v 2sa, united kingdom - magnesium hydroxide - oral suspension - magnesium hydroxide 415 mg/5ml - drugs for acid related disorders

Malta - inglise - Malta Medicines Authority

glaxo wellcome uk limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - ranitidine - syrup - ranitidine 150 mg - drugs for acid related disorders

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

physicians total care, inc. - erythromycin ethylsuccinate (unii: 1014ksj86f) (erythromycin - unii:63937kv33d), sulfisoxazole acetyl (unii: wbt5qh3ked) (sulfisoxazole - unii:740t4c525w) - erythromycin ethylsuccinate 200 mg in 5 ml - for treatment of acute otitis media in children that is caused by susceptible strains of haemophilus influenzae . erythromycin ethylsuccinate and sulfisoxazole acetyl for oral suspension is contraindicated in the following patient populations: use in pregnant women at term, in children less than 2 months of age, and in mothers nursing infants less than 2 months of age is contraindicated because sulfonamides may promote kernicterus in the newborn by displacing bilirubin from plasma proteins. erythromycin is contraindicated in patients taking terfenadine. (see precautions, drug interactions:.)

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

rebel distributors corp - erythromycin ethylsuccinate (unii: 1014ksj86f) (erythromycin - unii:63937kv33d), sulfisoxazole acetyl (unii: wbt5qh3ked) (sulfisoxazole - unii:740t4c525w) - erythromycin ethylsuccinate 200 mg in 5 ml - for treatment of acute otitis media in children that is caused by susceptible strains of haemophilus influenzae . erythromycin ethylsuccinate and sulfisoxazole acetyl for oral suspension is contraindicated in the following patient populations: use in pregnant women at term, in children less than 2 months of age, and in mothers nursing infants less than 2 months of age is contraindicated because sulfonamides may promote kernicterus in the newborn by displacing bilirubin from plasma proteins. erythromycin is contraindicated in patients taking terfenadine. (see precautions, drug interactions:.)

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - ranitidine hydrochloride - oral solution - 15mg/1ml